1. FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma. Issue 8 (13th May 2022) Authors: Merino, Margret; Kasamon, Yvette; Li, Hongshan; Ma, Lian; Leong, Ruby; Zhou, Jiaxi; Reaman, Gregory; Chambers, Wiley; Richardson, Nicholas; Theoret, Marc; Pazdur, Richard; Gormley, Nicole Journal: Pediatric blood & cancer Issue: Volume 69:Issue 8(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA‐NCI roundtable symposium. Issue 12 (December 2014) Authors: Landgren, Ola; Gormley, Nicole; Turley, Danielle; Owen, Roger G.; Rawstron, Andy; Paiva, Bruno; Barnett, David; Arroz, Maria; Wallace, Paul; Durie, Brian; Yuan, Constance; Dogan, Ahmet; Stetler‐Stevenson, Maryalice; Marti, Gerald E. Journal: American journal of hematology Issue: Volume 89:Issue 12(2014:Dec.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature. Issue 9 (29th April 2020) Authors: Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S. Christopher; Kanapuru, Bindu; Gormley, Nicole; Waldron, Peter E. Journal: American journal of hematology Issue: Volume 95:Issue 9(2020:Sep.) Page Start: E218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. Issue 5 (May 2022) Authors: Thanarajasingam, Gita; Minasian, Lori M; Bhatnagar, Vishal; Cavalli, Franco; De Claro, R Angelo; Dueck, Amylou C; El-Galaly, Tarec C; Everest, Neil; Geissler, Jan; Gisselbrecht, Christian; Gormley, Nicole; Gribben, John; Horowitz, Mary; Ivy, S Percy; Jacobson, Caron A; Keating, Armand; Kluetz, Pa... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health. (27th July 2021) Authors: Chang, Elaine; Pelosof, Lorraine; Lemery, Steven; Gong, Yutao; Goldberg, Kirsten B.; Farrell, Ann T.; Keegan, Patricia; Veeraraghavan, Janaki; Wei, Guo; Blumenthal, Gideon M.; Amiri-Kordestani, Laleh; Singh, Harpreet; Fashoyin-Aje, Lola; Gormley, Nicole; Kluetz, Paul G.; Pazdur, Richard; Beaver, ... Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health. (27th July 2021) Authors: Chang, Elaine; Pelosof, Lorraine; Lemery, Steven; Gong, Yutao; Goldberg, Kirsten B.; Farrell, Ann T.; Keegan, Patricia; Veeraraghavan, Janaki; Wei, Guo; Blumenthal, Gideon M.; Amiri‐Kordestani, Laleh; Singh, Harpreet; Fashoyin‐Aje, Lola; Gormley, Nicole; Kluetz, Paul G.; Pazdur, Richard; Beaver, ... Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint. Issue 5 (May 2022) Authors: Richardson, Nicholas C; Kasamon, Yvette; Pazdur, Richard; Gormley, Nicole Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗